Beauchamp KA - Search Results

1

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen.

Beauchamp KA, Johansen Taber KA, Muzzey D. Beauchamp KA, et al. Genet Med. 2022 Apr;24(4):968. doi: 10.1016/j.gim.2022.02.011. Genet Med. 2022. PMID: 35394430 Free article. No abstract available.

2

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen.

Beauchamp KA, Johansen Taber KA, Muzzey D. Beauchamp KA, et al. Genet Med. 2019 Sep;21(9):1948-1957. doi: 10.1038/s41436-019-0455-8. Epub 2019 Feb 14. Genet Med. 2019. PMID: 30760891 Free PMC article.

3

Systematic design and comparison of expanded carrier screening panels.

Beauchamp KA, Muzzey D, Wong KK, Hogan GJ, Karimi K, Candille SI, Mehta N, Mar-Heyming R, Kaseniit KE, Kang HP, Evans EA, Goldberg JD, Lazarin GA, Haque IS. Beauchamp KA, et al. Genet Med. 2018 Jan;20(1):55-63. doi: 10.1038/gim.2017.69. Epub 2017 Jun 22. Genet Med. 2018. PMID: 28640244 Free PMC article.

4

Clinical utility of expanded carrier screening: results-guided actionability and outcomes.

Johansen Taber KA, Beauchamp KA, Lazarin GA, Muzzey D, Arjunan A, Goldberg JD. Johansen Taber KA, et al. Among authors: beauchamp ka. Genet Med. 2019 May;21(5):1041-1048. doi: 10.1038/s41436-018-0321-0. Epub 2018 Oct 11. Genet Med. 2019. PMID: 30310157 Free PMC article.

5

Sequencing as a first-line methodology for cystic fibrosis carrier screening.

Beauchamp KA, Johansen Taber KA, Grauman PV, Spurka L, Lim-Harashima J, Svenson A, Goldberg JD, Muzzey D. Beauchamp KA, et al. Genet Med. 2019 Nov;21(11):2569-2576. doi: 10.1038/s41436-019-0525-y. Epub 2019 Apr 30. Genet Med. 2019. PMID: 31036917 Free PMC article.

6

Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening.

Beauchamp KA, Taber KAJ, Grauman PV, Spurka L, Lim-Harashima J, Svenson A, Goldberg JD, Muzzey D. Beauchamp KA, et al. Genet Med. 2019 Oct;21(10):2407-2408. doi: 10.1038/s41436-019-0543-9. Genet Med. 2019. PMID: 31089271 Free PMC article.

7

Clinical validity of expanded carrier screening: Evaluating the gene-disease relationship in more than 200 conditions.

Balzotti M, Meng L, Muzzey D, Johansen Taber K, Beauchamp K, Curation Team MG, Curation Team BG, Mar-Heyming R, Buckley B, Moyer K. Balzotti M, et al. Hum Mutat. 2020 Aug;41(8):1365-1371. doi: 10.1002/humu.24033. Epub 2020 May 21. Hum Mutat. 2020. PMID: 32383249 Free PMC article.

8

Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification.

Hogan GJ, Vysotskaia VS, Beauchamp KA, Seisenberger S, Grauman PV, Haas KR, Hong SH, Jeon D, Kash S, Lai HH, Melroy LM, Theilmann MR, Chu CS, Iori K, Maguire JR, Evans EA, Haque IS, Mar-Heyming R, Kang HP, Muzzey D. Hogan GJ, et al. Among authors: beauchamp ka. Clin Chem. 2018 Jul;64(7):1063-1073. doi: 10.1373/clinchem.2018.286823. Epub 2018 May 14. Clin Chem. 2018. PMID: 29760218

9

MSMBuilder2: Modeling Conformational Dynamics at the Picosecond to Millisecond Scale.

Beauchamp KA, Bowman GR, Lane TJ, Maibaum L, Haque IS, Pande VS. Beauchamp KA, et al. J Chem Theory Comput. 2011 Oct 11;7(10):3412-3419. doi: 10.1021/ct200463m. J Chem Theory Comput. 2011. PMID: 22125474 Free PMC article.

10

Building a More Predictive Protein Force Field: A Systematic and Reproducible Route to AMBER-FB15.

Wang LP, McKiernan KA, Gomes J, Beauchamp KA, Head-Gordon T, Rice JE, Swope WC, Martínez TJ, Pande VS. Wang LP, et al. Among authors: beauchamp ka. J Phys Chem B. 2017 Apr 27;121(16):4023-4039. doi: 10.1021/acs.jpcb.7b02320. Epub 2017 Apr 6. J Phys Chem B. 2017. PMID: 28306259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters